Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
Authors
Keywords
-
Journal
iScience
Volume 24, Issue 9, Pages 102941
Publisher
Elsevier BV
Online
2021-08-04
DOI
10.1016/j.isci.2021.102941
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Engineered Recombinant Single Chain Variable Fragment of Monoclonal Antibody Provides Protection to Chickens Infected with H9N2 Avian Influenza
- (2020) Deimante Lukosaityte et al. Vaccines
- Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract
- (2020) Pengfei Cui et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
- (2020) Dominic Wichmann et al. ANNALS OF INTERNAL MEDICINE
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
- (2020) Hai-qiong Yu et al. EUROPEAN RESPIRATORY JOURNAL
- The convalescent sera option for containing COVID-19
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- SARS-CoV-2: a storm is raging
- (2020) Savannah F. Pedersen et al. JOURNAL OF CLINICAL INVESTIGATION
- Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia
- (2020) Tongqiang Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study
- (2020) Amitava Banerjee et al. LANCET
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Rapid COVID-19 vaccine development
- (2020) Barney S. Graham SCIENCE
- Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
- (2020) Ren Mao et al. Lancet Gastroenterology & Hepatology
- Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City
- (2020) Eva W. Cheung et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
- (2020) Fabian Schmidt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
- (2020) Ching-Lin Hsieh et al. SCIENCE
- A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
- (2020) Ahmed O. Hassan et al. CELL
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters
- (2020) Lisa H. Tostanoski et al. NATURE MEDICINE
- Growth, detection, quantification, and inactivation of SARS-CoV-2
- (2020) James Brett Case et al. VIROLOGY
- Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
- (2020) Antonella Fara et al. Open Biology
- A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2
- (2020) Mohammed A. Rohaim et al. Vaccines
- Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
- (2020) Jun-Gyu Park et al. JOURNAL OF VIROLOGICAL METHODS
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
- (2020) Weina Sun et al. EBioMedicine
- A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
- (2020) Weina Sun et al. Vaccines
- Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
- (2020) Carlo Cervia et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Novel avian paramyxovirus-based vaccine vectors expressing the Ebola virus glycoprotein elicit mucosal and humoral immune responses in guinea pigs
- (2019) Asuka Yoshida et al. Scientific Reports
- Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections
- (2019) Cynthia Calzas et al. Frontiers in Immunology
- Noninvasive vaccination against infectious diseases
- (2018) Zhichao Zheng et al. Human Vaccines & Immunotherapeutics
- Fat-associated lymphoid clusters control local IgM secretion during pleural infection and lung inflammation
- (2016) Lucy H. Jackson-Jones et al. Nature Communications
- Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs
- (2016) Avijit Dutta et al. Scientific Reports
- Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies
- (2015) Shujing Wang et al. Protein & Cell
- Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults
- (2013) Akira Ainai et al. Human Vaccines & Immunotherapeutics
- Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs
- (2012) Dongni Kong et al. VIROLOGY
- Newcastle Disease Virus-Vectored Rabies Vaccine Is Safe, Highly Immunogenic, and Provides Long-Lasting Protection in Dogs and Cats
- (2011) J. Ge et al. JOURNAL OF VIROLOGY
- Multiple Infections with Seasonal Influenza A Virus Induce Cross‐Protective Immunity against A(H1N1) Pandemic Influenza Virus in a Ferret Model
- (2010) Karen L. Laurie et al. JOURNAL OF INFECTIOUS DISEASES
- Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector
- (2010) J. Kortekaas et al. VACCINE
- Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1
- (2010) Sunil K. Khattar et al. VACCINE
- Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
- (2010) Joshua M. DiNapoli et al. VACCINE
- Newcastle Disease Virus-Vectored Vaccines Expressing the Hemagglutinin or Neuraminidase Protein of H5N1 Highly Pathogenic Avian Influenza Virus Protect against Virus Challenge in Monkeys
- (2009) J. M. DiNapoli et al. JOURNAL OF VIROLOGY
- Optimization of Human Immunodeficiency Virus Gag Expression by Newcastle Disease Virus Vectors for the Induction of Potent Immune Responses
- (2008) E. Carnero et al. JOURNAL OF VIROLOGY
- A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals
- (2008) Lijuan Yang et al. VIROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started